SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-106528
Filing Date
2020-09-18
Accepted
2020-09-18 16:25:28
Documents
7
Period of Report
2020-11-02
Effectiveness Date
2020-09-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2030766-1_def14a.htm DEF 14A 1079075
2 GRAPHIC lg_phibrocorp-4c.jpg GRAPHIC 266855
3 GRAPHIC sg_thomasdagger-bw.jpg GRAPHIC 102539
4 GRAPHIC tm2030766d1-bc_ceo4c.jpg GRAPHIC 1024455
5 GRAPHIC tm2030766d1-fc_base4c.jpg GRAPHIC 288210
6 GRAPHIC tm2030766d1-pc_1proxycardbw.jpg GRAPHIC 1747950
7 GRAPHIC tm2030766d1-pc_2proxycardbw.jpg GRAPHIC 1252181
  Complete submission text file 0001104659-20-106528.txt   7372731
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 201184281
SIC: 2834 Pharmaceutical Preparations